John C. Araujo

5.2k total citations
89 papers, 2.5k citations indexed

About

John C. Araujo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, John C. Araujo has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in John C. Araujo's work include Prostate Cancer Treatment and Research (51 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Cancer, Lipids, and Metabolism (16 papers). John C. Araujo is often cited by papers focused on Prostate Cancer Treatment and Research (51 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Cancer, Lipids, and Metabolism (16 papers). John C. Araujo collaborates with scholars based in United States, United Kingdom and Canada. John C. Araujo's co-authors include Christopher J. Logothetis, Paul G. Corn, Gary E. Gallick, Ana M. Aparicio, Nizar M. Tannir, Lance C. Pagliaro, Eric Rohren, Homer A. Macapinlac, Elba Etchebehere and Nancy Swanston and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

John C. Araujo

83 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C. Araujo United States	25	1.4k	1.1k	851	567	509	89	2.5k
Anna Berkenblit United States	26	1.3k 0.9×	1.4k 1.3×	1.6k 1.9×	710 1.3×	258 0.5×	57	3.2k
William K. Kelly United States	23	1.5k 1.0×	1.0k 1.0×	805 0.9×	503 0.9×	462 0.9×	50	2.7k
G. Deplanque France	23	812 0.6×	1.3k 1.2×	633 0.7×	542 1.0×	221 0.4×	77	2.3k
Wael A. Harb United States	23	759 0.5×	1.4k 1.3×	923 1.1×	423 0.7×	273 0.5×	118	2.5k
Michael T. Schweizer United States	33	2.2k 1.5×	1.1k 1.0×	929 1.1×	746 1.3×	444 0.9×	144	3.1k
Vincent Haddad United Kingdom	16	1.3k 0.9×	1.5k 1.4×	907 1.1×	485 0.9×	252 0.5×	36	2.9k
Vincenzo Damiano Italy	26	1.2k 0.8×	1.9k 1.8×	1.4k 1.6×	459 0.8×	336 0.7×	62	3.2k
Hiroaki Asano Japan	28	1.4k 0.9×	1.1k 1.0×	1.3k 1.5×	842 1.5×	170 0.3×	82	2.8k
Morten Mau‐Sørensen Denmark	28	527 0.4×	1.2k 1.1×	1.1k 1.3×	541 1.0×	187 0.4×	130	2.7k
Annarita Destro Italy	29	1.6k 1.1×	1.5k 1.4×	1.2k 1.4×	621 1.1×	304 0.6×	58	3.7k

Countries citing papers authored by John C. Araujo

Since Specialization

Citations

This map shows the geographic impact of John C. Araujo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Araujo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Araujo more than expected).

Fields of papers citing papers by John C. Araujo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Araujo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Araujo. The network helps show where John C. Araujo may publish in the future.

Co-authorship network of co-authors of John C. Araujo

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Araujo. A scholar is included among the top collaborators of John C. Araujo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Araujo. John C. Araujo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monsalve, Alberto, John C. Araujo, Nelson Vejar, et al.. (2025). Microbiologically influenced corrosion of Al–Cu–Li alloy by Pseudomonas aeruginosa. Journal of Materials Research and Technology. 36. 5286–5297.

Campbell, Matthew T., Shi‐Ming Tu, John C. Araujo, et al.. (2024). Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell Tumors. Clinical Genitourinary Cancer. 22(6). 102242–102242.

Halabi, Susan, Qian Yang, Bin Luo, et al.. (2023). External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer. Journal of Clinical Oncology. 41(15). 2736–2746. 14 indexed citations

Wang, Yinghong, Malek Shatila, Anusha Shirwaikar Thomas, et al.. (2023). Tu1734 RANDOMIZED CLINICAL TRIAL OF INFLIXIMAB VERSUS VEDOLIZUMAB FOR IMMUNE CHECKPOINT INHIBITOR RELATED COLITIS. Gastroenterology. 164(6). S–1101. 1 indexed citations

Wang, Jianbo, Matthew T. Campbell, Amishi Y. Shah, et al.. (2023). A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases.. Journal of Clinical Oncology. 41(6_suppl). TPS745–TPS745. 1 indexed citations

Davis, John W., Amado J. Zurita, Xuemei Wang, et al.. (2021). Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer. European Journal of Cancer. 157. 259–267. 12 indexed citations

Tsikkinis, Alexandros, Anh Hoang, Ana M. Aparicio, et al.. (2020). A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. 19(1). 22–31.e5. 13 indexed citations

Tsikkinis, Alexandros, Anh Hoang, Ana M. Aparicio, et al.. (2020). A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer. European Journal of Cancer. 127. 67–75. 5 indexed citations

Etchebehere, Elba, et al.. (2019). Is interim 18F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?. Radiologia Brasileira. 52(1). 33–40. 6 indexed citations

10.

Petros, Firas G., Roger Li, Bryan Fellman, et al.. (2019). Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 37(6). 354.e19–354.e26. 4 indexed citations

11.

Bilen, Mehmet Asım, Kenneth R. Hess, Sumit K. Subudhi, et al.. (2017). Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy. Cancer Chemotherapy and Pharmacology. 80(3). 583–589. 6 indexed citations

12.

Corn, Paul G., Neeraj Agarwal, John C. Araujo, & Guru Sonpavde. (2017). Taxane-based Combination Therapies for Metastatic Prostate Cancer. European Urology Focus. 5(3). 369–380. 30 indexed citations

13.

Etchebehere, Elba, John C. Araujo, Patricia S. Fox, et al.. (2015). Prognostic Factors in Patients Treated with ²²³Ra: The Role of Skeletal Tumor Burden on Baseline ¹⁸F-Fluoride PET/CT in Predicting Overall Survival. Journal of Nuclear Medicine. 56(8). 1177–1184. 100 indexed citations

14.

Aparicio, Ana M., Andrea Harzstark, Paul G. Corn, et al.. (2013). Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer. Clinical Cancer Research. 19(13). 3621–3630. 311 indexed citations

15.

Dayyani, Farshid, Andreas Varkaris, John C. Araujo, et al.. (2013). Increased serum insulin‐like growth factor‐1 levels are associated with prolonged response to dasatinib‐based regimens in metastatic prostate cancer. The Prostate. 73(9). 979–985. 9 indexed citations

16.

Ameri, Hossein, John C. Araujo, & Dan S. Gombos. (2012). Leuprolide Monotherapy for Choroidal Metastasis From Prostate Adenocarcinoma. Archives of Ophthalmology. 130(9). 1225–1225. 1 indexed citations

17.

Araujo, John C., Paul Mathew, Andrew J. Armstrong, et al.. (2011). Dasatinib combined with docetaxel for castration‐resistant prostate cancer. Cancer. 118(1). 63–71. 115 indexed citations

18.

Aparicio, Ana M., Vassiliki Tzelepi, John C. Araujo, et al.. (2010). Neuroendocrine prostate cancer xenografts with large‐cell and small‐cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles. The Prostate. 71(8). 846–856. 49 indexed citations

19.

Jonasch, Eric, Christopher G. Wood, Surena F. Matin, et al.. (2009). Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 27(25). 4076–4081. 136 indexed citations

20.

Kashanchi, Fatah, John C. Araujo, Jay Doniger, et al.. (1997). Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene. 14(3). 359–367. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact